Getein Biotech Inc (603387) — Cash Flow Quality Index
Getein Biotech Inc (603387) has a Cash Flow Quality Index of 1.95x as of September 2025. Operating cash flow of CN¥100.90 Million exceeds net income of CN¥51.74 Million, indicating high earnings quality where cash backs reported profits. Explore Getein Biotech Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Getein Biotech Inc Cash Flow Quality Index (2012–2025)
Historical Cash Flow Quality Index for Getein Biotech Inc across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Getein Biotech Inc.
Annual Cash Flow Quality Index for Getein Biotech Inc (2012–2025)
Year-by-year earnings quality comparison for Getein Biotech Inc.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.78x | CN¥392.59 Million | CN¥220.66 Million | ▼ -3.3% |
| 2024 | 1.84x | CN¥423.00 Million | CN¥229.88 Million | ▲ +56.9% |
| 2023 | 1.17x | CN¥333.22 Million | CN¥284.08 Million | ▲ +22.4% |
| 2022 | 0.96x | CN¥482.96 Million | CN¥503.94 Million | ▼ -8.7% |
| 2021 | 1.05x | CN¥432.36 Million | CN¥412.01 Million | ▲ +86.9% |
| 2020 | 0.56x | CN¥185.47 Million | CN¥330.31 Million | ▼ -13.0% |
| 2019 | 0.65x | CN¥225.73 Million | CN¥349.95 Million | ▼ -13.6% |
| 2018 | 0.75x | CN¥187.10 Million | CN¥250.64 Million | ▼ -24.6% |
| 2017 | 0.99x | CN¥191.91 Million | CN¥193.78 Million | ▼ -12.1% |
| 2016 | 1.13x | CN¥155.91 Million | CN¥138.32 Million | ▼ -3.0% |
| 2015 | 1.16x | CN¥121.73 Million | CN¥104.79 Million | ▼ -12.1% |
| 2014 | 1.32x | CN¥98.53 Million | CN¥74.56 Million | ▲ +45.2% |
| 2013 | 0.91x | CN¥59.72 Million | CN¥65.63 Million | ▼ -16.0% |
| 2012 | 1.08x | CN¥23.80 Million | CN¥21.96 Million | — |